Role of Intestinal Fatty Acid Binding Protein in Treated Inflammatory Bowel Diseases Patients

Liver Fatty Acid-binding Protein (L-FABP) as a Diagnostic Marker for Non-alcoholic Fatty Liver Disease

Intestinal Fatty-Acid-Binding Protein in Neonatal Necrotizing Enterocolitis

Study of Intestinal Fatty Acid Binding Protein-2 in Cirrhotic Patients and its Relation to Chronic Use of Proton Pump Inhibitors in Decompensated Cirrhosis

Fecal Lactoferrin as a New Marker of Disease Activity in Inflammatory Bowel Diseases

High Risk NAFLD among Patients with Irritable Bowel Syndrome: Frequency and Effect on Disease Severity

THE RELATION BETWEEN INTESTINAL FATTY ACIDS BINDING PROTEIN-2 AND CHRONIC USE OF PROTON PUMP INHIBITORS IN DECOMPENSATED CIRRHOSIS

Fecal Lactoferrin As A Diagnostic and Prognostic Marker in Egyptian IBD Patients

Prevalence of Non-Alcoholic Fatty Liver Disease and Its Association with Severity in Patients with Irritable Bowel Syndrome

Role of Fatty Acid Binding Protein 1 in Non- Alcoholic Fatty Pancreatic Disease with and without Diabetes Mellitus